Innoquest Pathology is Malaysia's largest independent diagnostic laboratory; and part of Pathology Asia Holdings (PAH), one of Southeast Asia's fastest-growing clinical diagnostics groups. Spanning 7 countries, with over 1,000 tests and approximately 100 million tests performed annually, PAH serves more than 8,000 hospitals, clinics, government bodies, and corporations, backed by over 70 in-house pathologists.
In Malaysia, Innoquest operates across 71+ sites, from Peninsular Malaysia to Sabah and Sarawak delivering seamless, rapid-turnaround diagnostics at scale.
For hospitals, our flagship solution is end-to-end on-site lab management: a fully managed service covering design, build, equipment, staffing, operations, quality assurance, and IT/LIS integration. Trusted by over 45 general and specialised hospitals across the region, we help institutions elevate diagnostic capability, strengthen margins, and free clinical teams to focus on what matters most: patient care.
Innoquest is the only multidisciplinary clinical laboratory in Malaysia holding dual accreditation of College of American Pathologists (CAP) and MS ISO 15189, a mark of world-class quality hospitals can rely on with confidence.
Beyond routine diagnostics, we offer advanced clinical genomics capabilities across reproductive health, oncology, cardiology, rare diseases, and neurology through our subsidiaries, DNA Lab and LifeStrands, providing partners with a single, trusted pathway to the full spectrum of modern diagnostics.
Ready to elevate your hospital's diagnostic capability? Partner with us. Email: enquiry@innoquest.com.my